Ocean Biomedical Valuation
| OCEAWDelisted Stock | 0.01 0 66.67% |
Ocean Biomedical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Ocean Biomedical from analyzing the company fundamentals such as Total Debt of 16.3 M, number of shares shorted of 2.31 K, and Retained Earnings of (205.53 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ocean Biomedical's price fluctuation is out of control at this time. Calculation of the real value of Ocean Biomedical is based on 3 months time horizon. Increasing Ocean Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ocean pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Ocean Biomedical. Since Ocean Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ocean Pink Sheet. However, Ocean Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.011 | Real 0.0104 | Hype 0.01 | Naive 0.003517 |
The intrinsic value of Ocean Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ocean Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ocean Biomedical helps investors to forecast how Ocean pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ocean Biomedical more accurately as focusing exclusively on Ocean Biomedical's fundamentals will not take into account other important factors: Ocean Biomedical Total Value Analysis
Ocean Biomedical is now forecasted to have takeover price of 0 with market capitalization of 0, debt of 16.3 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ocean Biomedical fundamentals before making investing decisions based on enterprise value of the companyOcean Biomedical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Ocean indicates not a very effective usage of assets in July.Ocean Biomedical Profitability Analysis
Net Loss for the year was (9.48 M) with profit before overhead, payroll, taxes, and interest of 0.About Ocean Biomedical Valuation
Our relative valuation model uses a comparative analysis of Ocean Biomedical. We calculate exposure to Ocean Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ocean Biomedical's related companies.8 Steps to conduct Ocean Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ocean Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ocean Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ocean Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ocean Biomedical's revenue streams: Identify Ocean Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ocean Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ocean Biomedical's growth potential: Evaluate Ocean Biomedical's management, business model, and growth potential.
- Determine Ocean Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ocean Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ocean Biomedical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Ocean Biomedical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 27.5 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Ocean Pink Sheet
If you are still planning to invest in Ocean Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocean Biomedical's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |